drugset / Trial / NCT02665832

Study of DWJ1351 in Healthy Male Volunteers

NCT02665832

Phase 1 Unknown 58 enrolled Daewoong Pharmaceutical Co. LTD.
RandomizedCrossoverOpen-labelBasic science

Summary

The purpose of this study is to compare the safety and pharmacokinetic characteristics of combination of amlodipine, olmesartan and rosuvastatin and DWJ1351 in healthy male volunteers

Timeline

Start
2016-01
Primary completion
2016-06
Completion
2016-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Amlodipine Other / unclassified
Subject DWJ1351 Unknown
Subject Olmesartan Other / unclassified
Subject Rosuvastatin Small molecule

Indications

No indication recorded.